Ethics in Liver Transplantation

ABSTRACT

In little over 30 years, liver transplantation has become the preferred therapy for many forms of end-stage liver disease. Improvements in immunosuppression, management of comorbidities, and surgical techniques have contributed to the spectacular improvement in patient and graft survival. Unfortunately, global application of this lifesaving therapy is limited by the inadequate supply of livers available for transplantation. Therefore, in an effort to minimize the mortality among patients waiting for liver transplantation, allocation based on the model for end-stage liver disease (MELD) has been adopted. Unfortunately, the current allocation system, initially developed to distribute deceased-donor kidneys for transplantation, has many deficiencies when applied to the allocation of deceased-donor livers. One such deficiency is exemplified by the unequal distribution of deceased-donor livers across and within regions with respect to MELD. Consequently, the national directive to transplant the sickest first among those awaiting liver transplantation has yet to be realized among all patients listed irrespective of region.

KEYWORDS

MELD - deceased-donor liver transplantation - allocation - rationing - national resource

REFERENCES

• 1 Wiesner R, Edwards E, Freeman R et al.. Model for end-stage liver disease (MELD) and allocation of donor livers.  Gastroenterology. 2003;  124 91-96
• 2 Freeman R B, Wiesner R H, Harper A et al.. The new liver allocation system: moving toward evidence-based transplantation policy.  Liver Transpl. 2002;  8 851-858
• 3 Institute of Medicine Committee on Organ Procurement and Transplantation Policy .Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC; National Academy Press 1999: 1-29
• 4 Kremers W K, van IJperen M, Kim W R et al.. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.  Hepatology. 2004;  39 764-769
• 5 Freeman R B, Wiesner R H, Edwards E et al.. Results of the first year of the new liver allocation plan.  Liver Transpl. 2004;  10 7-15
• 6 Freeman R B, Wiesner R H, Roberts J P et al.. Improving liver allocation: MELD and PELD.  Am J Transplant. 2004;  4(suppl 9) 114-131
• 7 Trotter J F, Osgood M J. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.  JAMA. 2004;  291 1871-1874
• 8 Schaffer III R L, Kulkarni S, Harper A, Millis J M, Cronin II D C. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.  Liver Transpl. 2003;  9 1211-1215
• 9 Koch T, Denike K. Equality vs. efficiency: the geography of solid organ distribution in the USA.  Ethics Place Environ. 2001;  4 45-56
• 10 Pritsker A B, Daily P, Pritsker K D. Using simulation to craft a national organ transplantation policy. Proceedings of the 1996 Winter Simulation Conference 1996: 1163-1169
• 11 Burdick J F. National and local forces in organ allocation.  Transplant Proc. 1999;  31 1333-1336
• 12 Redwood H. Why ration health care? An international study of the United Kingdom, France, Germany and public sector health care in the USA. Heinz Redwood and The Institute for the Study of Civil Society 2000